ISHRAK OMAR
SEC CIK 1523102 · EDGAR
BoughtSold
Most active insiders at AMGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Santos Esteban | EVP, Ops | — | $20.77M |
| 2 | Grygiel Nancy A. | SVP, CCO | — | $2.65M |
| 3 | Gordon Murdo | EVP, Gbl Commercial Ops | — | $2.32M |
| 4 | Khosla Rachna | SVP, Business Development | — | $1.65M |
| 5 | Miller Derek | SVP, Human Resources | — | $1.57M |
| 6 | Busch Matthew C. | VP, CAO, Fin | — | $375.8K |
| 7 | Klotman Mary E. | Dir | — | — |
| 8 | Bradner James E. | EVP, Research, Development | — | — |
| 9 | Drake Michael V | Dir | — | — |
| 10 | Griffith Peter H. | EVP, CFO | — | — |
| 14 | ISHRAK OMAR | Dir | — | — |
Transactions 25
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-10 20:24 | 2026-08-07 | AMGN | Amgen | ISHRAK OMAR | Dir | A - Grant | $0.00 | +85.17 | 7,486 | +1% | $0 | |
| 2026-05-21 19:02 | 2026-05-19 | AMGN | Amgen | ISHRAK OMAR | Dir | A - Grant | $0.00 | +665 | 7,359 | +10% | $0 | |
| 2026-05-07 20:40 | 2026-05-05 | AMGN | Amgen | ISHRAK OMAR | Dir | A - Grant | $0.00 | +106.19 | 6,694 | +2% | $0 | |
| 2025-11-12 | 2025-11-07 | AMGN | Amgen | ISHRAK OMAR | Dir | A - Grant | $0.00 | +218.61 | 6,508 | +3% | $0 | |
| 2025-08-12 | 2025-08-08 | AMGN | Amgen | ISHRAK OMAR | Dir | A - Grant | $0.00 | +121.43 | 6,242 | +2% | $0 | |
| 2025-05-28 | 2025-05-23 | AMGN | Amgen | ISHRAK OMAR | Dir | A - Grant | $0.00 | +809 | 6,084 | +15% | $0 | |
| 2025-05-08 | 2025-05-06 | AMGN | Amgen | ISHRAK OMAR | Dir | A - Grant | $0.00 | +129.42 | 5,276 | +3% | $0 | |
| 2024-11-06 | 2024-11-04 | AMGN | Amgen | ISHRAK OMAR | Dir | A - Grant | $0.00 | +220.88 | 5,081 | +5% | $0 | |
| 2024-08-13 | 2024-08-09 | AMGN | Amgen | ISHRAK OMAR | Dir | A - Grant | $0.00 | +108.53 | 4,833 | +2% | $0 | |
| 2024-06-04 | 2024-05-31 | AMGN | Amgen | ISHRAK OMAR | Dir | A - Grant | $0.00 | +719 | 4,696 | +18% | $0 | |
| 2024-05-08 | 2024-05-07 | AMGN | Amgen | ISHRAK OMAR | Dir | A - Grant | $0.00 | +116.55 | 3,977 | +3% | $0 | |
| 2023-11-07 | 2023-11-03 | AMGN | Amgen | ISHRAK OMAR | Dir | A - Grant | $0.00 | +240.87 | 3,813 | +7% | $0 | |
| I | 2023-08-10 | 2023-01-30 | INTC | Intel | ISHRAK OMAR | Dir | P - Purchase | $28.05 | +86 | 86 | New | +$2,412 |
| 2023-08-10 | 2023-08-08 | AMGN | Amgen | ISHRAK OMAR | Dir | A - Grant | $0.00 | +124.62 | 3,525 | +4% | $0 | |
| 2023-05-23 | 2023-05-19 | AMGN | Amgen | ISHRAK OMAR | Dir | A - Grant | $0.00 | +939 | 3,401 | +38% | $0 | |
| D | 2023-05-15 | 2023-05-11 | INTC | Intel | ISHRAK OMAR | Dir | M - OptEx | — | +4,828 | 54.8K | +10% | — |
| 2023-05-03 | 2023-05-02 | AMGN | Amgen | ISHRAK OMAR | Dir | A - Grant | $0.00 | +137.73 | 2,462 | +6% | $0 | |
| 2022-11-10 | 2022-11-08 | AMGN | Amgen | ISHRAK OMAR | Dir | A - Grant | $0.00 | +222.31 | 2,302 | +11% | $0 | |
| 2022-08-11 | 2022-08-09 | AMGN | Amgen | ISHRAK OMAR | Dir | A - Grant | $0.00 | +130.86 | 2,070 | +7% | $0 | |
| 2022-05-19 | 2022-05-17 | AMGN | Amgen | ISHRAK OMAR | Dir | A - Grant | $0.00 | +855 | 1,931 | +79% | $0 | |
| D | 2022-05-16 | 2022-05-12 | INTC | Intel | ISHRAK OMAR | Dir | M - OptEx | — | +3,720 | 49.9K | +8% | — |
| 2022-05-04 | 2022-05-02 | AMGN | Amgen | ISHRAK OMAR | Dir | A - Grant | $0.00 | +140.74 | 1,076 | +15% | $0 | |
| 2022-02-24 | 2022-02-22 | INTC | Intel | ISHRAK OMAR | Dir | P - Purchase | $45.11 | +11.0K | 46.2K | +31% | +$497.3K | |
| 2021-11-01 | 2021-10-28 | INTC | Intel | ISHRAK OMAR | Dir | P - Purchase | $48.02 | +20.0K | 35.2K | +132% | +$960.4K | |
| 2021-08-10 | 2021-08-06 | AMGN | Amgen | ISHRAK OMAR | Dir | A - Grant | $0.00 | +760 | 935 | +434% | $0 |
Purchase Sale Sale after option exercise All abbreviations